Diabetes drug shows promise for sleep apnea in early study
NCT ID NCT07281196
First seen Dec 17, 2025 · Last updated May 16, 2026 · Updated 20 times
Summary
This study looked at whether semaglutide, a drug used for type 2 diabetes and weight loss, can help people with sleep apnea. Fifteen adults with obesity or diabetes and sleep apnea took semaglutide for up to 4 weeks. Researchers measured changes in breathing pauses during sleep (AHI), weight, and other health markers to see if the drug could ease sleep apnea symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLEEP APNEA SYNDROME (OSAS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Fengxian District Central Hospital
Shanghai, 201499, China
Conditions
Explore the condition pages connected to this study.